Breast Ultrasound With Tom Stavros | Diagnosis, Screening, Staging, Biomarkers & Niche Applications is organized by World Class CME and will be held from Sep 20 - 23, 2018 at The Ritz-Carlton, Pentagon City, Arlington, Virginia, United States of America.
The target audience for this medical event is Radiologists and radiology residents/fellows, breast surgeons, sonographers, radiology technologists and advanced practitioners who desire to learn, in-depth, how to use breast ultrasound in a clinical practice setting for diagnosis, screening and staging of breast disease. This CME Conference has been approved for a maximum of 24.75 AMA PRA Category 1 Credits and 7.25 SAMs Credits.
Conference Objectives are :
• Understand the differences in pre-test probabilities and guidelines for interpretation between diagnostic, supplemental screening, and MRI-directed indications for breast ultrasound and how that affects management and interpretation.
• Select the most appropriate ultrasound equipment, machine settings, and scan techniques for better diagnostic evaluations
• Understand the anatomic and histopathologic basis for ultrasound appearances
• Correlate areas of clinical, mammographic, screening ultrasound, or MRI concern with ultrasound, and to understand the anatomic and histopathologic basis for ultrasound appearances
• Identify both mass and non-mass sonographic findings that are suspicious for malignancy, how to use them in classifying breast masses and in staging breast cancers.
• Understand a new way of classifying ultrasound features that can aid in more objectively using and achieving ACR PPV benchmarks for BI-RADS 4 subcategories and function better as biomarkers than prior methods of classification.
• Identify the few truly suspicious complex cystic and solid masses that require biopsy and to distinguish them from the myriad of non-simple breast cysts that are definitively benign.
• Understand the roles of ultrasound and galactography in diagnosis and guiding biopsy in patients presenting with nipple discharge
• Recognize the range of normal and abnormal appearances for breast implants
• Enhance ultrasound-guided breast biopsy and interventional skills
• Utilize the new classification system of breast malignancies that is based upon site of origin -- within ducts, within TDLUs, or within peri-ductal mesenchymal tissues for better correlation with prognosis
• Understand the appropriate role for supplemental bilateral whole breast ultrasound as well as other ancillary imaging modalities in women with negative but dense mammograms
• Improve detection and correct classification of small invasive breast cancers while minimizing false positive ultrasound examinations
• Learn how to overcome the headwinds in establishing a supplemental whole breast ultrasound program in women with dense breast
• Learn to distinguish normal from abnormal regional lymph nodes, determine whether abnormal nodes are more likely metastatic or reactive, and how Z0011 might affect current management of nodes
• Become familiar with a new functional imaging platform called Opto-acoustic Imaging
• Understand the benefits of integrating this new technology into breast ultrasound, so that radiologist can significantly increase specificity when analyzing a mass, and potentially obviate the need for many breast biopsies.
Time: 7:00 am - 12:30 pm
Speakers: Tom Stavros, MD, Michael J. Ulissey, MD
Additional details will be posted as soon as they are available.
|Contact No.||:||(888) 207-9105|
|Registration Type||End Date||Price|
|Physician - Registration Fee||19 Sep,2018||USD 1395.00|
|Sonographer - Registration Fee||19 Sep,2018||USD 995.00|
|Military, Retired, VA Physician - Registration Fee||19 Sep,2018||USD 1195.00|
|Resident/Fellow, NP, PA - Registration Fee||19 Sep,2018||USD 1095.00|